Michael B. LazarSenior Advisor (New York)
Michael Lazar has participated in over $5 billion of private debt and private equity investments across his 25-year career. Mr. Lazar co-founded BlackRock Kelso Capital Corporation (“BKCC”) and served on its Investment Committee and was its Chief Operating Officer from its formation in 2004 until March, 2015. Mr. Lazar served on the BKCC Board of Directors and served as a managing member of BlackRock Kelso Capital Advisors (now 52nd Street Advisors), BKCC’s investment advisor until March, 2015. In addition, he served as a managing member of BlackRock Kelso Mezzanine Advisors. Previously, Mr. Lazar was a Principal and Managing Director (partner) at Kelso & Company, L.P., one of the oldest and most established firms specializing in private equity investing. Having originally joined Kelso & Company, L.P. in 1993, Mr. Lazar was involved in Kelso & Company, L.P.’s private equity transactions since that time.
Prior to joining Kelso, Mr. Lazar worked in the Acquisition Finance Group at Chemical Securities, Inc. (predecessor to J.P. Morgan Securities Inc.) where his responsibilities included working with financial sponsors on the analysis, evaluation and financing of leveraged buyouts. He began his career in the Corporate Finance and Structured Finance Groups at Chemical Bank, where he focused on financings for leveraged companies.
Mr. Lazar received a B.A. degree, cum laude, from Dartmouth College. Mr. Lazar has served as Co-Chair of the Leadership Council of the Naomi Berrie Diabetes Center at Columbia University Medical Center and serves as a Trustee of the Rye Country Day School, as well as President of the Rye Country Day School Alumni Executive Board. Mr. Lazar previously served as a member of the Dartmouth College Fund Committee and as a Director of the New York Division of the March of Dimes. In addition, Mr. Lazar has served on the public and private Boards of Directors of certain Kelso portfolio companies and is a Director of Gordon Brothers Finance Company.